We are live on ! Find out more
URGN icon

UroGen Pharma
URGN

84 hedge funds and large institutions have $382M invested in UroGen Pharma in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 17

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

53% more capital invested

Capital invested by funds: $250M → $382M (+$132M)

6% more funds holding

Funds holding: 79 → 84 (+5)

0.61% more ownership

Funds ownership: 66.27% → 66.88% (+0.61%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

21% less call options, than puts

Call options by funds: $5.93M | Put options by funds: $7.48M

Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
39
Reduced
17
Closed
8
Calls
$5.93M
Puts
$7.48M
Net Calls
-$1.55M
Net Calls Change
-$2.89M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$22.1M
2
CS
Credit Suisse
Switzerland
+$5.97M
3
HCM
Horton Capital Management
Pennsylvania
+$3.22M
4
Millennium Management
Millennium Management
New York
+$2.6M
5
VOYA Investment Management
VOYA Investment Management
Georgia
+$2.48M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$12M
2
HCM
Highline Capital Management
New York
-$3.97M
3
PC
Pier Capital
Connecticut
-$2.68M
4
PM
Prosight Management
Texas
-$2.61M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.44M +$174K +7,117 +15%
SAM
27
Shikiar Asset Management
New York
$1.34M -$33.6K -1,375 -3%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$1.25M +$15.8K +647 +1%
AIM
29
ARK Investment Management
Florida
$1.23M +$743K +30,387 +181%
Norges Bank
30
Norges Bank
Norway
$1.18M +$1.1M +45,000 New
MIH
31
Meitav Investment House
Israel
$1.13M +$314K +12,849 +42%
Charles Schwab
32
Charles Schwab
California
$1.09M +$30.1K +1,232 +3%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.04M +$130K +5,300 +15%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.02M -$65.9K -2,698 -6%
CBA
35
Coastal Bridge Advisors
Connecticut
$966K – – –
Wells Fargo
36
Wells Fargo
California
$859K +$505K +20,666 +169%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$844K +$46.5K +1,901 +6%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$760K +$135K +5,539 +24%
EMG
39
ETF Managers Group
New Jersey
$673K +$70K +2,864 +12%
PPA
40
Parametric Portfolio Associates
Washington
$662K +$14.2K +579 +2%
PAI
41
Palo Alto Investors
California
$640K – – –
AS
42
Altshuler Shaham
Israel
$614K – – –
Jane Street
43
Jane Street
New York
$582K +$191K +7,797 +54%
AllianceBernstein
44
AllianceBernstein
Tennessee
$572K – – –
Citadel Advisors
45
Citadel Advisors
Florida
$548K -$1.16M -47,285 -69%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$520K +$88K +3,600 +22%
UBS AM
47
UBS AM
Illinois
$499K -$66K -2,700 -12%
AG
48
Aperio Group
California
$433K +$405K +16,575 New
Barclays
49
Barclays
United Kingdom
$412K +$131K +5,367 +52%
BHB
50
Bank Hapoalim BM
Israel
$387K +$8.55K +350 +2%
1
2
3 4

URGN Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in UroGen Pharma (URGN) for Q2 2020, worth a combined $382M — up 53% from $250M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new URGN positions and 8 closed out — a net gain of 5 holders — while 39 added to existing stakes and 17 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $22.1M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $12M sold.

  • 84 institutional investors held UroGen Pharma (URGN) as of Q2 2020, up from 79 in Q1 2020.
  • Funds reported $382M of UroGen Pharma stock for Q2 2020, up 53% quarter-over-quarter.
  • 13 funds opened new UroGen Pharma positions in Q2 2020 and 8 closed out, a net change of +5 holders.
  • The largest UroGen Pharma buyer in Q2 2020 was Wellington Management Group, an estimated $22.1M added.
  • The largest UroGen Pharma seller in Q2 2020 was Baker Bros. Advisors, an estimated $12M sold.

Based on aggregated 13F filings for Q2 2020.